1. Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study. (October 2016) Authors: Lau, George; Benhamou, Yves; Chen, Guofeng; Li, Jin; Shao, Qing; Ji, Dong; Li, Fan; Li, Bing; Liu, Jialiang; Hou, Jinlin; Sun, Jian; Wang, Cheng; Chen, Jing; Wu, Vanessa; Wong, April; Wong, Chris L P; Tsang, Stella T Y; Wang, Yudong; Bassit, Leda; Tao, Sijia Journal: Lancet gastroenterology and hepatology Issue: Volume 1:Number 2(2016) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗